IVVD
Invivyd Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$384.61M
P/E Ratio
—
EPS
$-0.30
Beta
0.74
52W High
$3.07
52W Low
$0.48
50-Day MA
$1.58
200-Day MA
$1.63
Dividend Yield
—
Profit Margin
-98.30%
Forward P/E
44.64
PEG Ratio
—
About Invivyd Inc.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | $53.43M |
| Gross Profit (TTM) | $49.68M |
| EBITDA | $-54.80M |
| Operating Margin | -73.00% |
| Return on Equity | -34.00% |
| Return on Assets | -17.10% |
| Revenue/Share (TTM) | $0.31 |
| Book Value | $0.86 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | 7.20 |
| EV/Revenue | 3.108 |
| EV/EBITDA | 0.78 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 24.50% |
| Shares Outstanding | $282.80M |
| Float | $167.68M |
| % Insiders | 7.38% |
| % Institutions | 92.25% |
Historical Volatility
HV 10-Day
45.01%
HV 20-Day
116.22%
HV 30-Day
118.36%
HV 60-Day
98.46%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.00 target)
3
Buy1
HoldData last updated: 4/30/2026